BioSpace News Archive

Bimini Health Tech announced today it has acquired the exclusive rights to an Acellular Dermal Matrix (“ADM”) technology for the plastic and reconstructive surgery field of use.

Surmodics, Inc. (NASDAQ:SRDX) today announced that it has received formal feedback from the Food and Drug Administration (FDA; the Agency) related to its proposed approach to submit an amended premarket approval (PMA) application for the SurVeil™ drug-coated balloon (DCB).

Defence has completed all required pre-clinical and GLP studies on its lead compound AccuTOXTM as an injectable for solid tumors.

Peak Pharmaceuticals, Inc. (OTC Pink:PKPH) (“Peak” or the “Company”), announced that it has merged with Retrieve Medical, Inc., a software company that is commercializing a patented Clinical Documentation Improvement (CDI) platform, Retrieve DxTM, that enhances physicians’ ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more.

Children’s Hospital Los Angeles has appointed Lara Khouri, MBA, MPH, to be Executive Vice President and Chief Operating Officer.

Today, on National Diabetes Alert Day, Abacus Health Solutions announces the results of a cost savings analysis of their patented Diabetes Care Rewards Program, which incentivizes long-term health behaviors and dramatically reduces costs of diabetes care for insurers, employers and individuals.

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will be presenting at the 4th TCR-based Therapies for Solid Tumors Summit in Boston from April 3 to 5, 2023.

Medline today announced a distribution agreement with the national cooperative purchasing organization MMCAP Infuse to enhance supply chain operations for government facilities providing healthcare services throughout the country.

The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies.

Duke Street Bio, a UK-based biotech focusing on the discovery of novel precision medicine-based cancer therapies, today announced the strengthening of its executive leadership team with the appointment of Dónal Landers, MB BCh BAO, MBA, DPM, FFPM as Chief Medical Officer.